| scholarly article | Q13442814 |
| P50 | author | Christine M. Lovly | Q82683894 |
| P2093 | author name string | Helen Piwnica-Worms | |
| Julie K Schwarz | |||
| P433 | issue | 8 | |
| P921 | main subject | phosphorylation | Q242736 |
| P304 | page(s) | 598-609 | |
| P577 | publication date | 2003-06-01 | |
| P1433 | published in | Molecular Cancer Research | Q2751014 |
| P1476 | title | Regulation of the Chk2 protein kinase by oligomerization-mediated cis- and trans-phosphorylation | |
| P478 | volume | 1 |
| Q37294000 | 'AND' logic gates at work: Crystal structure of Rad53 bound to Dbf4 and Cdc7. |
| Q37501480 | 14-3-3 proteins, FHA domains and BRCT domains in the DNA damage response |
| Q43106462 | A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpoint |
| Q41125698 | Analysis of somatic mutations across the kinome reveals loss-of-function mutations in multiple cancer types |
| Q37011615 | Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2. |
| Q42021047 | Autoinhibition and autoactivation of the DNA replication checkpoint kinase Cds1 |
| Q37103465 | CCT241533 is a potent and selective inhibitor of CHK2 that potentiates the cytotoxicity of PARP inhibitors |
| Q43169381 | CHEK2 I157T associates with familial and sporadic colorectal cancer |
| Q35889614 | CHEK2 contribution to hereditary breast cancer in non-BRCA families |
| Q39505275 | CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute. |
| Q34977480 | CHK2 kinase in the DNA damage response and beyond |
| Q90355409 | Checkpoint Responses to DNA Double-Strand Breaks |
| Q38943445 | Chk2 and REGγ-dependent DBC1 regulation in DNA damage induced apoptosis |
| Q30577899 | Chk2 prevents mitotic exit when the majority of kinetochores are unattached |
| Q92524053 | Computational analysis of high-risk SNPs in human CHK2 gene responsible for hereditary breast cancer: A functional and structural impact |
| Q39398050 | Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing |
| Q93164325 | Criteria of the German Consortium for Hereditary Breast and Ovarian Cancer for the Classification of Germline Sequence Variants in Risk Genes for Hereditary Breast and Ovarian Cancer |
| Q39125363 | DNA damage-induced cell cycle regulation and function of novel Chk2 phosphoresidues. |
| Q27678684 | Fragment-based screening maps inhibitor interactions in the ATP-binding site of checkpoint kinase 2 |
| Q34291464 | Geminin is required for zygotic gene expression at the Xenopus mid-blastula transition |
| Q36546469 | Identification of novel, in vivo active Chk1 inhibitors utilizing structure guided drug design |
| Q50643738 | Inhibition of Twist1-mediated invasion by Chk2 promotes premature senescence in p53-defective cancer cells. |
| Q34236881 | Interdependent phosphorylation within the kinase domain T-loop Regulates CHK2 activity |
| Q37235809 | Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. |
| Q39644012 | Lack of DNA polymerase μ affects the kinetics of DNA double-strand break repair and impacts on cellular senescence |
| Q37099799 | Maternal embryonic leucine zipper kinase (MELK) reduces replication stress in glioblastoma cells |
| Q64071922 | Mouse Model of Mutated in Colorectal Cancer Gene Deletion Reveals Novel Pathways in Inflammation and Cancer |
| Q39641600 | Part II. Initial molecular and cellular characterization of high nitric oxide-adapted human tongue squamous cell carcinoma cell lines |
| Q28297156 | Phospho-Ser/Thr-binding domains: navigating the cell cycle and DNA damage response |
| Q47113405 | Proteome Stability as a Key Factor of Genome Integrity |
| Q24315969 | Regulation of Chk2 ubiquitination and signaling through autophosphorylation of serine 379 |
| Q33886979 | Regulation of the DNA Damage Response to DSBs by Post-Translational Modifications |
| Q38798535 | Regulatory roles of conserved phosphorylation sites in the activation T-loop of the MAP kinase ERK1 |
| Q36557533 | Repair of topoisomerase I-mediated DNA damage |
| Q35997577 | Response to DNA damage of CHEK2 missense mutations in familial breast cancer |
| Q26795781 | Targeting the Checkpoint to Kill Cancer Cells |
| Q24305557 | The CHK2-BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells |
| Q30651039 | The FHA domain determines Drosophila Chk2/Mnk localization to key mitotic structures and is essential for early embryonic DNA damage responses |
| Q35255891 | The PARP inhibitor PJ34 causes a PARP1-independent, p21 dependent mitotic arrest |
| Q39257841 | The role of DNA damage repair and Chk2 protein in hyper-radiosensitivity of lung adenocarcinoma A549 cells |
| Q24294605 | Trans-activation of the DNA-damage signalling protein kinase Chk2 by T-loop exchange |
| Q30160418 | Xenopus Cds1 is regulated by DNA-dependent protein kinase and ATR during the cell cycle checkpoint response to double-stranded DNA ends |
Search more.